ArticleExperimental eye research2016

Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease.

Rebecca E H Whiting et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.